|
|
||||||||
Original Research Communications |
Background: Tocotrienols, lipid-soluble antioxidants with vitamin E activity, have been reported to lower LDL-cholesterol concentrations and platelet aggregation in men, but results are contradictory.
Objective: To examine in detail the effects of a vitamin E concentrate rich in tocotrienols on serum lipoproteins and on platelet function in men at risk for cardiovascular disease.
Design: In this randomized, double-blind, placebo-controlled parallel trial, 20 men received daily for 6 wk 4 capsules, each containing 35 mg tocotrienols and 20 mg
-tocopherol; 20 other men received 4 capsules daily, each providing 20 mg
-tocopherol. All men had concentrations of serum total cholesterol between 6.5 and 8.0 mmol/L or lipoprotein(a) concentrations >150 mg/L.
Results: Compliance was confirmed by changes in serum tocopherol and tocotrienol concentrations. Serum LDL cholesterol in the tocotrienol group was 4.80 mmol/L before and 4.79 mmol/L after intervention, and increased from 4.70 to 4.86 mmol/L in the placebo group (95% CI for the difference: -0.54, 0.19 mmol/L; P = 0.333). Also, changes in HDL cholesterol, triacylglycerol, lipoprotein(a), and lipid peroxide concentrations did not differ between the groups. After adjustment for differences in initial values, no effects were found on collagen-induced platelet aggregation velocity, maximum aggregation, or thromboxane B2 formation in citrated whole blood. ATP release, however, was lower in the tocotrienol group. Urinary thromboxane B2 and 11-keto-thromboxane B2 concentrations and coagulation and fibrinolytic measures did not change.
Conclusion: The tocotrienol supplements used had no marked favorable effects on the serum lipoprotein profile or on platelet function in men with slightly elevated lipid concentrations.
Key Words: Tocotrienols cholesterol HDL cholesterol triacylglycerols aggregation coagulation fibrinolysis lipid peroxides humans thromboxane B2 platelets
This article has been cited by other articles:
![]() |
J. Arnaud, M. Bost, D. Vitoux, J. Labarere, P. Galan, H. Faure, S. Hercberg, J.-C. Bordet, A.-M. Roussel, and P. Chappuis Effect of Low Dose Antioxidant Vitamin and Trace Element Supplementation on the Urinary Concentrations of Thromboxane and Prostacyclin Metabolites J. Am. Coll. Nutr., October 1, 2007; 26(5): 405 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fairus, R. M Nor, H. M Cheng, and K. Sundram Postprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of {alpha}-tocopherol. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 835 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schaffer, W. E. Muller, and G. P. Eckert Tocotrienols: Constitutional Effects in Aging and Disease J. Nutr., February 1, 2005; 135(2): 151 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. SEN, S. KHANNA, and S. ROY Tocotrienol: The Natural Vitamin E to Defend the Nervous System? Ann. N.Y. Acad. Sci., December 1, 2004; 1031(1): 127 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A Mustad, C. A Smith, P. P Ruey, N. K Edens, and S. J DeMichele Supplementation with 3 compositionally different tocotrienol supplements does not improve cardiovascular disease risk factors in men and women with hypercholesterolemia Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1237 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A.J.M. Kerckhoffs, F. Brouns, G. Hornstra, and R. P. Mensink Effects on the Human Serum Lipoprotein Profile of {beta}-Glucan, Soy Protein and Isoflavones, Plant Sterols and Stanols, Garlic and Tocotrienols J. Nutr., September 1, 2002; 132(9): 2494 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Packer, S. U. Weber, and G. Rimbach Molecular Aspects of {{alpha}}-Tocotrienol Antioxidant Action and Cell Signalling J. Nutr., February 1, 2001; 131(2): 369S - 373. [Abstract] [Full Text] |
||||
![]() |
T. M. Black, P. Wang, N. Maeda, and R. A. Coleman Palm Tocotrienols Protect ApoE +/- Mice from Diet-Induced Atheroma Formation J. Nutr., October 1, 2000; 130(10): 2420 - 2426. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |